Tags : Anti-RS Virus Drug Candidates


Shionogi Signs a Research Collaboration with UBE Industries for the

Shots: Shionogi and UBE Industries collaborates for development of anti-RS (respiratory syncytial) virus drugs to treat Respiratory Syncytial Virus (RSV) infection The focus of the agreement is to combine Shionogi’s drug discovery platform with UBE’s drug design technology for SAR (Structure-Activity Relationship) study UBE Industries’ Drug discovery platform uses polymer synthesis technology for the development […]Read More